Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis
Open Access
- 1 December 2006
- Vol. 55 (12) , 1739-1745
- https://doi.org/10.1136/gut.2006.095299
Abstract
Background: Limited data on a short series of patients suggest that lymphocytic enteritis (classically considered as latent coeliac disease) may produce symptoms of malabsorption, although the true prevalence of this situation is unknown. Serological markers of coeliac disease are of little diagnostic value in identifying these patients. Aims: To evaluate the usefulness of human leucocyte antigen-DQ2 genotyping followed by duodenal biopsy for the detection of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease and to assess the clinical relevance of lymphocytic enteritis diagnosed with this screening strategy. Patients and methods: 221 first-degree relatives of 82 DQ2+ patients with coeliac disease were consecutively included. Duodenal biopsy (for histological examination and tissue transglutaminase antibody assay in culture supernatant) was carried out on all DQ2+ relatives. Clinical features, biochemical parameters and bone mineral density were recorded. Results: 130 relatives (58.8%) were DQ2+, showing the following histological stages: 64 (49.2%) Marsh 0; 32 (24.6%) Marsh I; 1 (0.8%) Marsh II; 13 (10.0%) Marsh III; 15.4% refused the biopsy. 49 relatives showed gluten sensitive enteropathy, 46 with histological abnormalities and 3 with Marsh 0 but positive tissue transglutaminase antibody in culture supernatant. Only 17 of 221 relatives had positive serological markers. Differences in the diagnostic yield between the proposed strategy and serology were significant (22.2% v 7.2%, pConclusions: The high number of symptomatic patients with lymphocytic enteritis (Marsh I) supports the need for a strategy based on human leucocyte antigen-DQ2 genotyping followed by duodenal biopsy in relatives of patients with coeliac disease and modifies the current concept that villous atrophy is required to prescribe a gluten-free diet.Keywords
This publication has 33 references indexed in Scilit:
- Case-finding in coeliac disease should be intensifiedBest Practice & Research Clinical Gastroenterology, 2005
- Coeliac disease: changing viewsBest Practice & Research Clinical Gastroenterology, 2005
- A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kitsJournal of Clinical Pathology, 2002
- Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recoveryAmerican Journal of Gastroenterology, 2000
- Should relatives of coeliacs with mild clinical complaints undergo a small-bowel biopsy despite negative serology?European Journal of Gastroenterology & Hepatology, 2000
- The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrateEuropean Journal of Gastroenterology & Hepatology, 1999
- Gluten-sensitive disease with mild enteropathyGastroenterology, 1996
- Use of Serological Markers as a Screening Test in Family Members of Patients with Celiac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 1994
- HLA‐DQB1 and ‐DQA1 typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hoursTissue Antigens, 1993
- Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.Archives of Disease in Childhood, 1990